Results 241 to 250 of about 118,303 (321)

Factors Associated With Opioid Agonist Treatment Engagement and Harm Reduction Service Use: Findings From the New South Wales Opioid Dependence Survey

Drug and Alcohol Review, Volume 45, Issue 3, March 2026.
ABSTRACT Introduction Opioid agonist treatment (OAT) is one of the most effective treatments for opioid dependence, but there can be barriers to accessing treatment. This study examined characteristics associated with OAT engagement—never, previous or current—among people with opioid dependence in NSW, Australia, following recent reforms to OAT access.
Thomas Santo Jr, Chrianna Bharat, Craig Rodgers, Mary Harrod, Sophia Taylor, Emma Zahra, Rachel Sutherland, Amy Peacock, Jason Grebely, Matthew Hickman, Michael Farrell, Louisa Degenhardt   +11 more
wiley   +1 more source

Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children. [PDF]

J Clin Pharmacol
Watt KM, Thompson EJ, Lam L, Zimmerman K, Hornik CP, Atz AM, Fernandez A, Hupp SR, Bhatt-Mehta V, Benjamin DK, Anand R, Cohen-Wolkowiez M, Gonzalez D, Smith PB, Capparelli EV, Best Pharmaceuticals for Children Act — Pediatric Trials Network Steering Committee.   +15 more
europepmc   +1 more source

More than a medication: The lived meaning and value of long-acting injectable buprenorphine. [PDF]

Drug Alcohol Depend Rep
Donaldson SR, Dillon JF, Radley A.
europepmc   +1 more source

Exploring the Utility and Appropriateness of Dose Thresholds for Issuing of Public Drug Alerts on High‐Dose MDMA: A Qualitative Study

Drug and Alcohol Review, Volume 45, Issue 3, March 2026.
ABSTRACT Introduction Drug alerts are sometimes issued when samples are found to exceed a pre‐determined dose threshold. In Australia, it is common for alerts to be issued when MDMA pills contain ≥ 150 mg of MDMA free‐base or 179 mg hydrochloride. Nineteen such alerts were issued in Australia in 2024, raising concerns that repeat alerts may lose impact
Jack Freestone, Harriet MacDonald, Stassi Kypri, Brendan Clifford, Krista J. Siefried, Nadine Ezard   +5 more
wiley   +1 more source

Concerns and Experiences of Alcohol and Other Drug Healthcare Staff Regarding Intoxication Detection and Driving Safety of Opioid Treatment Clients

Drug and Alcohol Review, Volume 45, Issue 3, March 2026.
ABSTRACT Introduction Accurate detection and management of intoxication is critical in healthcare, particularly in alcohol and other drug (AOD) settings. While alcohol intoxication is often reliably assessed, drug intoxication is harder to detect. For clients receiving opioid agonist treatment (OAT), intoxication status can impact safety, treatment ...
Daniel T. Winter, Gabriel A. Verón, Carolyn A. Day, Nicholas Lintzeris, Paul S. Haber, Lauren A. Monds   +5 more
wiley   +1 more source

Neuroleptic Malignant Syndrome Induced by Multiple Antipsychotics in a Patient Receiving Methadone. [PDF]

Cureus
Suzuki N.
europepmc   +1 more source

Distal urethral obstruction in an eight‐week‐old colt with struvite urolithiasis

Equine Veterinary Education, Volume 38, Issue 3, Page e130-e136, March 2026.
Summary An 8‐week‐old Thoroughbred colt presented with acute colic signs. Physical examination and transcutaneous ultrasound of the abdomen and penis revealed a urinary tract obstruction in the distal urethra due to urolithiasis. A distal urethrotomy over the site of obstruction was performed to remove the urolith and relieve the obstruction.
M. T. Connaughton, A. Wilson, C. M. Baldwin   +2 more
wiley   +1 more source

IV. Drug Abuse: Indiana\u27s Response [PDF]

, 2011
Griglak, William F.
core   +1 more source

Harm reduction engagement and ongoing opioid use among adults receiving methadone or buprenorphine in Philadelphia. [PDF]

Harm Reduct J
Brincheiro W, Chiles N, Jangro W, Haahr R, Weinstein LC.   +4 more
europepmc   +1 more source

Older Age Is Associated With Long‐Term Retention in Buprenorphine Treatment for Opioid Use Disorder

Journal of the American Geriatrics Society, Volume 74, Issue 3, Page 676-684, March 2026.
ABSTRACT Background Opioid use disorder (OUD) among older adults is a fast‐growing public health problem. However, little is known about treatment outcomes among older adults in office‐based buprenorphine programs. Thus, our objective was to examine how age is associated with buprenorphine treatment outcomes among adults with OUD who initiate ...
Justina L. Groeger, Tiffany Lu, Andrea Jakubowski, Chenshu Zhang, Yuting Deng, Hector Perez, Frank DiRenno, Benjamin M. Jadow, Benjamin T. Hayes, Shadi Nahvi, Chinazo O. Cunningham, Joanna L. Starrels   +11 more
wiley   +1 more source